Johnson & Johnson’s $8.9 billion baby powder deal faces key test in Oakland trial
Johnson & Johnson’s first jury trial in nearly two years over allegations that its talc-based baby powder causes cancer could influence plaintiffs weighing the $8.9 billion settlement offer put forth
Read More
Recent Comments